Hodgkin-limfóma: vizsgálatok itt: Csehország
5 of 7 trials · From ClinicalTrials.gov and EU CTIS (euclinicaltrials.eu), checked 2026. november 18.. Ask the study team whether a trial fits you.
- 1/2. fázisTaking peopleA Study to Evaluate Safety, Tolerability, Pharmacokinetics, and Anti-Tumor Activity of Glofitamab in Monotherapy and in Combination with Chemoimmunotherapy in Pediatric and Young Adult Participants with Relapsed/Refractory Mature B-Cell Non-Hodgkin Lymphoma
- Where
- Prague
- Életkor
- Up to 17 év
- People
- 37 worldwide
- Run by
- F. Hoffmann-La Roche AG
See details and how to join2023-504264-41-00 - 3. fázisNot yet taking people in CsehországA Clinical Trial to Evaluate Efficacy, Safety, and Pharmacokinetics of Gamunex in Participants With Secondary Antibody Deficiency Associated With Chronic Lymphocytic Leukemia, Multiple Myeloma, or Non-Hodgkin Lymphoma
- Where
- Ostrava, Plzen 23, Praha 10
- Életkor
- 18 év and over
- People
- 49 worldwide
- Run by
- Grifols Biologicals, LLC
See details and how to joinNCT07582432 · EU 2026-526803-31-00 - 1. fázisTaking peopleA Phase 1b Open-Label Study to Evaluate the Safety and Anti-cancer Activity of Loncastuximab Tesirine in Combination with Other Anti-cancer Agents in Patients with Relapsed or Refractory B-cell Non-Hodgkin Lymphoma (LOTIS-7)
- Where
- Ostrava, Prague, Prague 10
- Életkor
- 18 év and over
- People
- 121 worldwide
- Run by
- ADC Therapeutics SA
See details and how to joinNCT04970901 · EU 2024-512089-32-00 - 3. fázisBefejeződöttA trial to learn how effective and safe odronextamab is compared to standard of care for adult participants with previously treated aggressive B-cell Non-Hodgkin Lymphoma.
- Where
- Prague 10
- Életkor
- 18 év and over
- People
- 132 worldwide
- Run by
- Regeneron Pharmaceuticals Inc.
See details and how to joinNCT06230224 · EU 2022-502783-21-00 - 1. fázisTaking peopleCART19 Cells Effects in Patients with Relapsed or Refractory Acute Lymphoblastic Leukemia and Non-Hodgkin's Lymphoma
- Where
- Prague
- Életkor
- 18 év to 80 év
- People
- 10
- Run by
- Institute of Hematology and Blood Transfusion, Czech Republic
See details and how to joinNCT05054257 · EU 2024-510815-30-00